Increasing plasma NEFA levels in obesity may lead to the persistent loss of function of beta-cells, causing severe dysfunction in glucose-stimulated insulin secretion pathways and impaired insulin biosynthesis. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.